期刊
JOURNAL OF CONTROLLED RELEASE
卷 237, 期 -, 页码 168-176出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2016.07.015
关键词
Paclitaxel; Nanocrystals; Biodistribution; PEG; Surfactant; Tumor
资金
- Lilly Endowment Seed Grant Program
- Chao Endowment
We have previously tested paclitaxel nanocrystals (PTX-NCs) in tumor murine models and learned that the nano-crystal formulation could achieve similar and superior anticancer efficacy to the conventional Taxol (R) formulation, but with significantly reduced side-effects. The nanocrystals were not coated with any surfactants and a majority of the injected dose was taken up by the liver (>40%), while a minimal amount was present in the blood circulation and quickly eliminated. The aim of this work was to treat the surface of PTX-NCs with PEG-based polymers and examine the impact by surface coating on biodistribution, pharmacokinetics, and tumor retention. Testing in tumor-bearing mice showed that PTX-NCs treated with Pluronic (R) F68 (PEG-PPG-PEG block polymer) significantly enhanced blood circulation of the drug and accumulation in tumor tissue. The absolute amount reaching the tumor, however, was still minimal relative to the dose. (C) 2016 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据